Compare IRON & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | FRPT |
|---|---|---|
| Founded | 2017 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2020 | 2014 |
| Metric | IRON | FRPT |
|---|---|---|
| Price | $69.83 | $57.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $103.18 | $76.94 |
| AVG Volume (30 Days) | 384.6K | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 183.87 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $1,102,015,000.00 |
| Revenue This Year | N/A | $11.34 |
| Revenue Next Year | $283.52 | $9.13 |
| P/E Ratio | ★ N/A | $59.88 |
| Revenue Growth | N/A | ★ 13.01 |
| 52 Week Low | $40.00 | $46.45 |
| 52 Week High | $99.50 | $86.00 |
| Indicator | IRON | FRPT |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 61.86 |
| Support Level | $64.48 | $47.58 |
| Resistance Level | $71.85 | $67.21 |
| Average True Range (ATR) | 3.26 | 2.56 |
| MACD | 0.04 | 1.15 |
| Stochastic Oscillator | 64.61 | 97.02 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.